EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.5 | medicine | the results suggest that the irreversible inactivation of NAT1 by cysplatin may at least partly contribute to the pharmacological and, or toxicological effects of cisplatin | Homo sapiens |
2.3.1.5 | molecular biology | results show that cisplatin inactivates the NAT1 enzyme by forming an adduct with the catalytic cysteine residue of the enzyme | Mus musculus |
2.3.1.5 | molecular biology | results show that cisplatin inactivates the NAT1 enzyme by forming an adduct with the catalytic cysteine residue of the enzyme | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.5 | expressed as a His-tagged fusion protein in Escherichia coli | Homo sapiens |
2.3.1.5 | into the pET28a vector for expression in Escherichia coli BL21DE3 cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.5 | cisplatin | exposure of MCF-7 breast cancer cells to cisplatin at clinically relevant concentrations (below 0.4 nM) causes significant dose-dependent inhibition of the endogenous NAT1 enzyme. The incubation of NAT1 with various concentrations of cisplatin results in the dose-dependent modification of cysteine residues, as indicated by the disappearance of fluorescein-conjugated iodoacetamide labeling | Homo sapiens | |
2.3.1.5 | cisplatin | treating C57BL/6J mice with cisplatin significantly decreases murine Nat2 (murine counterpart of human NAT1) enzymatic function in the liver (25% inhibition), kidney (40% inhibition), and blood cells (50% inhibition) | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.5 | Homo sapiens | - |
- |
- |
2.3.1.5 | Mus musculus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.1.5 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.5 | blood | - |
Mus musculus | - |
2.3.1.5 | kidney | - |
Mus musculus | - |
2.3.1.5 | liver | - |
Mus musculus | - |
2.3.1.5 | MCF-7 cell | - |
Homo sapiens | - |
2.3.1.5 | MDA-MB-231 cell | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.3.1.5 | additional information | - |
wild-type enzyme 100% activity, + cisplatin 9%, + AcCoA and cisplatin 13 - 77%, depending on the AcCoA concentration, + CoA and cysplatin 7% | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.5 | acetyl-CoA + 4-aminobenzoic acid | - |
Mus musculus | CoA + N-acetyl-4-aminobenzoic acid | - |
? | |
2.3.1.5 | acetyl-CoA + p-aminobenzoic acid | - |
Homo sapiens | CoA + N-acetyl-4-aminobenzoic acid | - |
? | |
2.3.1.5 | acetyl-CoA + p-aminobenzoic acid | activity assay | Homo sapiens | CoA + N-acetyl-4-aminobenzoic acid | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.5 | arylamine N-acetyltransferase 1 | - |
Mus musculus |
2.3.1.5 | arylamine N-acetyltransferase 1 | - |
Homo sapiens |
2.3.1.5 | NAT1 | - |
Mus musculus |
2.3.1.5 | NAT1 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.5 | 37 | - |
assay at | Mus musculus |
2.3.1.5 | 37 | - |
assay at | Homo sapiens |
2.3.1.5 | 37 | - |
activity assay | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.5 | 7.5 | - |
assay at | Mus musculus |
2.3.1.5 | 7.5 | - |
assay at | Homo sapiens |
2.3.1.5 | 7.5 | - |
activity assay | Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.5 | additional information | - |
additional information | the second-order rate constant (kinact) for the inactivation of NAT1 by cisplatin is estimated at 700/M min | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.3.1.5 | 0.1 | - |
in MCF-7 breast cancer cells | Homo sapiens | cisplatin | |
2.3.1.5 | 0.1 | - |
in MCF7-cells, similar results with MDA-MB-231 cells | Homo sapiens | cisplatin |